Anacor Pharmaceuticals Inc (NASDAQ:ANAC)

56.81
Delayed Data
As of Mar 30
 +1.96 / +3.57%
Today’s Change
13.19
Today|||52-Week Range
58.08
+76.16%
Year-to-Date

Today’s Trading

Previous close54.85
Today’s open55.68
Day’s range55.04 - 57.99
Volume668,769
Average volume (3 months)571,799
Market cap$2.4B
Dividend yield--
Data as of 03/30/2015

Growth & Valuation

Earnings growth (last year)-198.10%
Earnings growth (this year)+19.26%
Earnings growth (next 5 years)+63.40%
Revenue growth (last year)+20.07%
P/E ratioNM
Price/Sales65.86
Price/Book--

Competitors

 Today’s
change
Today’s
% change
LCILannett Company Inc+2.35+3.59%
CLVSClovis Oncology Inc+1.51+2.05%
CBPOChina Biologic Produ...+1.16+1.27%
ASPXAuspex Pharmaceutica...+29.45+41.53%
Data as of 03/30/2015

Financials

Next reporting dateMay 7, 2015
EPS forecast (this quarter)-$0.49
Annual revenue (last year)$20.7M
Annual profit (last year)-$87.1M
Net profit margin-421.28%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Paul L. Berns
Chief Financial Officer &
Senior Vice President
Geoffrey M. Parker
Corporate headquarters
Palo Alto, California

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account